Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyPep-1 in Cutaneous Warts
NCT03846648Phase 1Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Mar 2019
- Primary completion
- Dec 2019
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cutaneous warts comparing CyPep-1 with Placebo (2 arms). Primary endpoints: Changes in heart rate, Changes in blood pressure (systolic and diastolic) and 2 more. Started Mar 2019; status: completed.
02
Drugs
cypep-1
03
Conditions
cutaneous warts
Beyond the preview
Go deeper on NCT03846648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03846648.